KASKELA LAW LLC: Important Deadline Established in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
59
KASKELA LAW LLC: Important Deadline Established in Shareholder Class Action Lawsuit Against Symantec Corp. – SYMC

RADNOR, Pa., May 17, 2018 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that a shareholder class action lawsuit has been filed against Symantec Corp. (NASDAQ: SYMC ) (“Symantec” or the “Company”) on behalf of purchasers of the Company’s securities between May 20, 2017 and May 10, 2018 , inclusive (the “Class Period”).

IMPORTANT DEADLINE:   Investors who purchased Symantec securities during the Class Period may, no later than July 16, 2018 , seek to be appointed as a lead plaintiff representative of the investor class.  Symantec investors are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585 or (888) 715 – 1740 prior to the deadline to discuss their legal rights and options.  Additional information about this action may also be found at www.kaskelalaw.com/case/symantec .

On May 10, 2018, Symantec disclosed that the “Audit Committee of the Board of Directors has commenced an internal investigation in connection with concerns raised by a former employee,” and that the Company “has voluntarily contacted the Securities and Exchange Commission to advise it that an internal investigation is underway.”  Additionally, Symantec disclosed that “[t]he Company’s financial results and guidance may be subject to change based on the outcome of the Audit Committee investigation,” and further, that it was “unlikely that the investigation will be completed in time for the Company to file its annual report on Form 10-K for the fiscal year ended March 30, 2018 in a timely manner.”

Following this news, shares of the Company’s stock declined in value by $9.66 per share, or over 33%, to close on May 11, 2018 at $19.52, on heavy trading volume.

The shareholder class action complaint alleges that Symantec and certain of its senior executive officers made false and misleading statements, and failed to disclose to investors that: (i) Symantec’s internal controls over financial reporting were materially weak and deficient; (ii) Symantec’s later disclosed “reporting of certain Non-GAAP measures including those that could impact executive compensation programs” would lead to heightened regulatory scrutiny by the SEC; (iii) as a result, Symantec’s public statements were materially false and misleading at all relevant times.  The complaint further alleges that, as a result of the foregoing, investors purchased Symantec’s securities at artificially inflated prices during the Class Period and suffered investment losses following the Company’s May 10, 2018 disclosures.

Symantec investors are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585 or (888) 715 – 1740, or via www.kaskelalaw.com/case/symantec , to discuss their legal rights and options with respect to this action prior to July 16, 2018 . 

Kaskela Law LLC exclusively prosecutes shareholder actions in state and federal courts throughout the country on behalf of investors.  For additional information about Kaskela Law LLC please visit www.kaskelalaw.com .

CONTACT:

KASKELA LAW LLC D. Seamus Kaskela, Esq. 201 King of Prussia Road Suite 650 Radnor, PA 19087 (484) 258 – 1585 (888) 715 – 1740 www.kaskelalaw.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 530

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 347

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 37

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 518

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading

Top 5 Most Recently Viewed Articles

Westlake Chemical Partners Schedules Q4 and Year-End Call

Updated Category News Views 158

Westlake Chemical Partners to Announce Earnings Soon Westlake Chemical Partners (NYSE: WLKP), based in Houston, is preparing to release its earnings report for the fourth quarter and full year 2024. This significant announcement is eagerly anticipated by investors and industry analysts alike. The earnings report is scheduled to be released prior to the market opening on a...

Continue Reading
Wabtec's Bold Move: Acquiring Evident's Tech Division

Updated Category News Views 144

Wabtec's Strategic Acquisition of Evident's Inspection Technologies Wabtec Corp, a leader in heavy industrial parts manufacturing, has made headlines with its recent decision to acquire the inspection technologies division of Evident for an impressive $1.78 billion. This acquisition reflects Wabtec's strategy to enhance its portfolio and strengthen its position within the...

Continue Reading
Insight into WisdomTree's Latest Fund Valuations

Updated Category News Views 184

Understanding Net Asset Values in ETFs Investors often seek knowledge about the net asset values (NAVs) of Exchange Traded Funds (ETFs), which play a critical role in determining how funds are valued and traded in the market. For instance, WisdomTree Issuer plc regularly offers updates concerning its funds, revealing the intricate details behind price fluctuations and...

Continue Reading
Investigation Announced Into Electronic Systems Technology, Inc.

Updated Category News Views 239

Investigation of Electronic Systems Technology, Inc. In a noteworthy development, the M&A Class Action Firm has announced an investigation into Electronic Systems Technology, Inc. (OTCMKTS: ELST). This firm, recognized as a top competitor in the 2024 ISS Securities Class Action Services Report, is dedicated to protecting shareholder interests. The firm, led by renowned...

Continue Reading
Fusion CBD Products Partners with Major League Baseball Teams

Updated Category News Views 291

Fusion CBD Products and Major League Baseball: A Growing Partnership Team sponsorship opportunities expand as the league embraces CBD's advantages. As the Major League Baseball (MLB) season unfolds, many players are facing injuries from early training sessions and games. Notable players like Heliot Ramos of the San Francisco Giants and Erik Miller have recently dealt with...

Continue Reading